Literature DB >> 9299540

Functional studies of human GLUT5: effect of pH on substrate selection and an analysis of substrate interactions.

S Kane1, M J Seatter, G W Gould.   

Abstract

The adsorption of D-fructose within the lumen of the human small intestine is thought to be mediated by the GLUT5 isoform of the human facilitative sugar transporter family. This isoform has been expressed in oocytes and shown to be capable of D-fructose transport. Some debate remains regarding the absolute substrate specificity of this isoform. To that end, we have undertaken an analysis of the functional properties of this protein when expressed in Xenopus oocytes. We have examined the pH dependence of transport activity, the ability to transport D-fructose versus deoxyglucose, and employed a range of sugar analogues to probe the nature of the exofacial substrate binding site. Our data show that the human GLUT5 isoform functions exclusively as a D-fructose transporter between pH 4.5 and 8. The Km for D-fructose was found to be 15 +/- 4 mM at pH 7. 5, and was relatively unaltered even at pH 4.5. Analysis of the effects of a range of compounds on GLUT5 function suggests that this isoform transports D-fructose preferentially in the furanose ring form. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299540     DOI: 10.1006/bbrc.1997.7204

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

2.  Reassessment of GLUT7 and GLUT9 as Putative Fructose and Glucose Transporters.

Authors:  Karolin Ebert; Maren Ludwig; Kerstin Elisabeth Geillinger; Gina Catalina Schoberth; Jasmin Essenwanger; Jürgen Stolz; Hannelore Daniel; Heiko Witt
Journal:  J Membr Biol       Date:  2017-01-12       Impact factor: 1.843

3.  Characterization of human glucose transporter (GLUT) 11 (encoded by SLC2A11), a novel sugar-transport facilitator specifically expressed in heart and skeletal muscle.

Authors:  H Doege; A Bocianski; A Scheepers; H Axer; J Eckel; H G Joost; A Schürmann
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

4.  Towards Selective Binding to the GLUT5 Transporter: Synthesis, Molecular Dynamics and In Vitro Evaluation of Novel C-3-Modified 2,5-Anhydro-D-mannitol Analogs.

Authors:  Natasha Rana; Marwa A Aziz; Ahmed K Oraby; Melinda Wuest; Jennifer Dufour; Khaled A M Abouzid; Frank Wuest; F G West
Journal:  Pharmaceutics       Date:  2022-04-10       Impact factor: 6.525

5.  Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2.

Authors:  Anita Au; Alina Gupta; Paul Schembri; Chris I Cheeseman
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

6.  Facilitative glucose transporter 9 expression affects glucose sensing in pancreatic beta-cells.

Authors:  Sarah A Evans; Manuel Doblado; Maggie M Chi; John A Corbett; Kelle H Moley
Journal:  Endocrinology       Date:  2009-10-06       Impact factor: 4.736

Review 7.  Regulation of the fructose transporter GLUT5 in health and disease.

Authors:  Veronique Douard; Ronaldo P Ferraris
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-04-08       Impact factor: 4.310

Review 8.  Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis.

Authors:  Anthony J Cura; Anthony Carruthers
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

Review 9.  Glucose transporters in brain in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-13       Impact factor: 3.657

10.  Establishing a yeast-based screening system for discovery of human GLUT5 inhibitors and activators.

Authors:  Joanna Tripp; Christine Essl; Cristina V Iancu; Eckhard Boles; Jun-Yong Choe; Mislav Oreb
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.